Parkman Healthcare Partners LLC Plus Therapeutics, Inc. Transaction History

Parkman Healthcare Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.3 - $8.4 $222,467 - $6.23 Million	-741,558 Reduced 55.97%	583,467 $186,000
Q3 2022 Nov 14, 2022	SELL	$0.48 - $7.5 $99,864 - $1.56 Million	-208,050 Reduced 13.57%	1,325,025 $590,000
Q2 2022 Aug 12, 2022	BUY	$0.46 - $1.02 $3,109 - $6,894	6,759 Added 0.44%	1,533,075 $828,000
Q1 2022 May 13, 2022	BUY	$0.87 - $1.32 $1.33 Million - $2.01 Million	1,526,316 New	1,526,316 $1.53 Million

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $36.6M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.